Search Results
Nov 20, 2025, 16:20 ET Los datos del estudio PMB-CT01 BAFFR-CAR T de PeproMene Bio seleccionados para dos ponencias en la ASH 2025
terapias previas dirigidas a CD19 o que presentaban enfermedad CD19 negativa. Los resultados provisionales de los estudios de fase 1 de escalamiento de dosis (NCT04690595, NCT05370430) respaldan a BAFF-R como una diana diferenciada diseñada para superar el escape antigénico de CD19, manteniendo una actividad
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 15:01 ET B2BINPAY Obtains El Salvador DASP Licence from CNAD, Cementing Its Lead in Regulated Crypto Payments
authorisation as a Digital Asset Service Provider (PSAD) from El Salvador's National Commission of Digital Assets (CNAD), under reference CNAD-047-2025 / CNAD-CD-402-2025.
More news about: B2BINPAY
Nov 20, 2025, 12:50 ET Hyundai IONIQ 6 N High-Performance EV Supercharges AutoMobility LA with North American Premiere
such as a motorsport-inspired swan-neck rear wing and widened fenders — deliver increased downforce while achieving a drag coefficient of just 0.27 Cd, ensuring stability at high-speeds and accentuating the IONIQ 6 N's aggressive, track-ready stance. Body rigidity has been strengthened
More news about: Hyundai Motor America
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
(B-NHL), including patients who failed prior CD19-directed therapy or presented with CD19-negative disease. Interim results from the Phase 1 dose-escalation studies (NCT04690595, NCT05370430) support BAFF-R as a differentiated target designed to overcome CD19 antigen escape while maintaining durable activity
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
(B-NHL), including patients who failed prior CD19-directed therapy or presented with CD19-negative disease. Interim results from the Phase 1 dose-escalation studies (NCT04690595, NCT05370430) support BAFF-R as a differentiated target designed to overcome CD19 antigen escape while maintaining durable activity
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 07:03 ET Opsera Announces Strategic Partnership with Koantek to Accelerate Databricks Adoption with Automated, Scalable DevOps for Data & AI Workloads
ecosystem: Koantek for award–winning migrations, implementations, and engineering, and Opsera for its Built on Databricks–certified platform that brings CI/CD, governance, observability, and automated release workflows to data and AI teams. Together, they offer a joint delivery model that pairs expert engineering
More news about: Opsera
Nov 20, 2025, 06:45 ET MacWeb Opens US East Region Cloud Service NY-Metro Data Center
New York-metro deployment brings Apple Mac mini and Mac Studio cloud servers for CI/CD, creative workloads, and Al inference at significantly lower cost than major cloud providers SANTA CLARA, Calif., Nov. 20, 2025
More news about: MacWeb
Nov 20, 2025, 05:00 ET Vipshop Reports Unaudited Third Quarter 2025 Financial Results
https://register-conf.media-server.com/register/BIa4c765227cd84d4fb940f017c5724abc Once pre-registration has been completed, each participant will receive dial-in numbers
More news about: Vipshop Holdings Limited
Nov 19, 2025, 21:56 ET Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs
TCEs: Antengene has built a robust portfolio of first/best-in-class programs targeting CD19×CD3, CDH6×CD3, ALPPL2×CD3, LY6G6D×CD3, GPRC5D×CD3, LILRB4×CD3, and FLT3×CD3, offering a wide therapeutic window for addressing unmet clinical needs across autoimmune diseases, solid tumors,
More news about: Antengene Corporation Limited
Nov 19, 2025, 17:00 ET BankFirst Capital Corporation Announces Cash Dividend
Alabama. BankFirst offers a wide variety of services for businesses and consumers. The Bank also offers internet banking, no-fee ATM access, checking, CD, and money market accounts, merchant services, mortgage loans, remote deposit capture, and more. For more information, visit
More news about: BankFirst Capital Corporation
Nov 19, 2025, 16:01 ET FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
anti-programmed death ligand 1 (PD-L1) in patients with ES-SCLC; DeLLphi-311, a Phase 1b study of IMDELLTRA in combination with etakafusp alfa (AB248), a novel CD8+ T-cell selective interleukin-2 (IL-2), in patients with ES-SCLC; and DeLLphi-312, a Phase 3 study evaluating tarlatamab as an induction and maintenance
More news about: Amgen
Nov 19, 2025, 14:30 ET Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Sealed Air Buyout
whether the board members of Sealed Air Corporation (NYSE: SEE) breached their fiduciary duties in connection with the proposed sale of the company to CD&R.
More news about: Johnson Fistel, PLLP
Nov 19, 2025, 10:13 ET Aperture Therapeutics Announces Development Candidate Targeting CD33 to Restore Microglial Homeostasis in FTD and ALS
protective effects of naturally occurring CD33 loss-of-function variants, which are associated with increased resilience to neurodegenerative disease, reduced neuroinflammation, and lower levels of pathological biomarkers linked to neural aging and degeneration. CD33 is a critical regulator of neuroinflammatory
More news about: Aperture Therapeutics
Nov 19, 2025, 09:00 ET Itential Unveils FlowAI, Delivering Agentic Orchestration for Infrastructure Operations
teams to build, adapt, and scale automations faster. Through agentic orchestration via MCP and intelligent workflows, Itential connects IT systems, CI/CD pipelines, and network infrastructure to deliver secure, end-to-end automation that's ready for the next generation of digital and AI-driven operations.
More news about: Itential
Nov 19, 2025, 08:30 ET Elektrobit maps the road to the right-sized SDV at CES 2026
Integration as code - scalable ECU development for SDVs: This demo highlights API-based extensions across CI/CD/CT workflows which automate configuration, scripting and test case creation, leveraging intelligent tooling, including AI-assisted automation, to deliver
More news about: Elektrobit
Nov 18, 2025, 12:47 ET AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
subcutaneously. Genmab's DuoBody-CD3 technology is designed to direct cytotoxic T cells selectively to elicit an immune response toward target cell types. Epcoritamab is designed to simultaneously bind to CD3 on T cells and CD20 on B cells and induces T-cell-mediated killing of CD20+ cells.vi
More news about: AbbVie
Nov 18, 2025, 12:19 ET Application Modernization Joins Caylent Accelerate™ Portfolio Delivering Engineering Velocity with Agentic Fleets
maintainability Framework and language upgrades including .NET, Java, and other enterprise platforms Automated CI/CD, testing, and observability integration to ensure reliability and continuous improvement Human-validated quality checks and
More news about: Caylent
Nov 18, 2025, 10:00 ET MSI Accelerates AI and Data Center Innovation with Next-Gen Server Solutions at SC25
CD270-S4051-X4: 2U 4-node server with 12 DDR5 DIMM slots and 3 PCIe 5.0 x4 U.2 NVMe bays per node. CD270-S4051-X2: 2U 2-node server
More news about: MSI
Nov 18, 2025, 09:03 ET noBGP Brings Raspberry Pi into the Vibe Coding Era with Pi GPT
networking, i GPT transforms the Pi into a fully functional development or production target that's secure, private, and seamlessly integrated into existing CI/CD and AI workflows. "pi GPT makes vibe coding truly accessible; no cloud bills, no setup headaches. Developers can just code and
More news about: noBGP
Nov 18, 2025, 07:28 ET 【硬核攻堅】【全球首創】先健G-Branch獲NMPA批准上市，登頂胸腹主動脈瘤微創治療的「珠峰」
D, et al. Endovascular versus conventional open surgical repair for thoracoabdominal aortic aneurysms. Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD012926.
More news about: 先健科技公司
Nov 17, 2025, 12:00 ET Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Sealed Air Corporation (NYSE: SEE)'s sale to funds affiliated with CD&R for $42.15 in cash per share. If you are a Sealed Air shareholder,
More news about: Halper Sadeh LLP
Nov 17, 2025, 11:00 ET Shareholder Alert: The Ademi Firm investigates whether Sealed Air Corporation is obtaining a Fair Price for its Public Shareholders
investigating Sealed Air (NYSE: SEE) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with CD&R.
More news about: Ademi LLP
Nov 17, 2025, 08:05 ET New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis
neutralize inflammation at the cellular source by blocking IL-23 and binding to CD64 (a receptor on cells that produce IL-23). Findings for dual-acting are limited to in vitro studies that demonstrate guselkumab binds to CD64, which is expressed on the surface of IL-23 producing cells in an inflammatory
More news about: Johnson & Johnson
Nov 17, 2025, 06:55 ET Sealed Air to be Acquired by CD&R for $10.3 Billion
next phase of growth in partnership with CD&R," said Dustin Semach, President and Chief Executive Officer of Sealed Air. "This transaction delivers significant and derisked value to Sealed Air stockholders while accelerating our ongoing transformation. CD&R's partnership will enhance our ability
More news about: Sealed Air
Nov 17, 2025, 06:30 ET Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC
31% (79/253) c,d (26, 37)
More news about: Nuvalent, Inc.